Amalgamated Financial’s Twist Bioscience TWST Stock Holding History

Amalgamated Financial’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$428K	Buy	+8,677	New	+$481K	﹤0.01%	1588

Other funds holding TWST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Amalgamated Financial's TWST Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Twist Bioscience (TWST) in Q1 2022: 8,677 shares worth $428K. The stake represents ﹤0.01% of the portfolio and ranks #1588 among its holdings.

213 funds tracked by Wall St. Rank hold TWST as of Q1 2022.

Amalgamated Financial held 8,677 shares of Twist Bioscience worth $428K as of Q1 2022.
Twist Bioscience was a new Amalgamated Financial position in Q1 2022.
Twist Bioscience made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1588 holding.
213 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.